Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pharmaceutical Preparations × Gynecologic × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Genitourinary 2 Lymphoid 1 Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 147 Carboplatin 109 Cisplatin 94 Bevacizumab 40 Topotecan 37 Gemcitabine 36 liposomal doxorubicin 32 Radiotherapy 29 Doxorubicin 27 Brachytherapy 26 Taxes 24 olaparib 20 Drug Therapy 20 pembrolizumab 18 Hyperthermic Intraperitoneal Chemotherapy 16 Chemotherapy, Adjuvant 16 human papillomavirus vaccine, L1 type 16, 18 15 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 14 Docetaxel 13 Neoadjuvant Therapy 12 Platinum 10 niraparib 9 Radiation 9 1,2-diaminocyclohexaneplatinum II citrate 9 Vaccines, Synthetic 8 Surgical Procedures, Operative 8 atezolizumab 7 Specimen Handling 7 Papillomavirus Vaccines 7 Letrozole 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02036164 2017-04-06

ACT-LACC

Navamindradhiraj University

Phase 3 Unknown

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡